Skip to content

"TO EVALUATE THE CLINICAL EFFICACY OF OF ASANATWAK LEPA IN AHIPUTANA(Napkin Rash)"

"A CLINICAL STUDY TO EVALUATE THE EFFICACY OF ASANATWAK LEPA IN AHIPUTANA W.S.R TO NAPKIN RASH"

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052575
Enrollment
30
Registered
2023-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L22- Diaper dermatitis

Interventions

None listed

Sponsors

Ramesh G Halalli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with 2 or more symptoms among the diagnostic criteria will be selected for the study. H/O of symptoms of AHIPUTANA/ Napkin Rash not more than 7 days.

Exclusion criteria

Exclusion criteria: Children suffering from any other systemic disorders. Children who have other generalised skin infections other than AHIPUTANA.

Design outcomes

Primary

MeasureTime frame
To evaluate the clinical efficacy of Asanatwak Lepa in Ahiputana(Napkin Rash).Timepoint: 1YEAR

Secondary

MeasureTime frame
To study the concept of Napkin Rash with comparable entities in AyurvedaTimepoint: 6month

Countries

India

Contacts

Public ContactRamesh G Halalli

Associate Professor department of Kaumarbhrity Alvas ayurveda medical collage vidyagiri moodbidari

drnarayanpai@gmail.com9902329719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026